References

The role of galectins in immunity and infection

10.1038/s41577-022-00829-7 · 2023 · External reference

Galectin-3: A key player in microglia-mediated neuroinflammation and Alzheimer’s disease

10.1186/s13578-021-00592-7 · 2021 · External reference

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration

10.1038/s41419-022-05058-3 · 2022 · External reference

Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease

10.1007/s00401-019-02013-z · 2019 · External reference

Galectin-3 promotes brain injury by modulating the phenotype of microglia via binding TLR-4 after intracerebral hemorrhage

10.18632/aging.205014 · 2023 · External reference

Elevated galectin-3 is associated with aging, multiple sclerosis, and oxidized phosphatidylcholine-induced neurodegeneration

10.1523/jneurosci.2312-22.2023 · 2023 · External reference

Huntington disease: New insights into molecular pathogenesis and therapeutic opportunities

10.1038/s41582-020-0389-4 · 2020 · External reference

Microglial and astrocytic responses in the human midcingulate cortex in Huntington’s disease

10.1002/ana.26753 · 2023 · External reference

Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease

10.1038/s41467-019-11441-0 · 2019 · External reference

Scrutinising the conformational ensemble of the intrinsically mixed-folded protein galectin-3

10.3390/molecules29122768 · 2024 · External reference

Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis

10.1002/brb3.75 · 2012 · External reference

A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity

10.1186/s12987-020-00230-3 · 2020 · External reference

Current small molecule-based medicinal chemistry approaches for neurodegeneration therapeutics

10.1002/cmdc.202300705 · 2024 · External reference

Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy

10.1126/sciadv.abo0789 · 2022 · External reference

Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins

10.1007/s00401-017-1722-x · 2017 · External reference

Intracellular galectins sense cytosolically exposed glycans as danger and mediate cellular responses

10.1186/s12929-021-00713-x · 2021 · External reference

Microglial lectins in health and neurological diseases

10.3389/fnmol.2018.00158 · 2018 · External reference

Aryl hydrocarbon receptor mediates both proinflammatory and anti-inflammatory effects in lipopolysaccharide-activated microglia

10.1002/glia.22805 · 2015 · External reference

TREM2—A key player in microglial biology and Alzheimer disease

10.1038/s41582-018-0072-1 · 2018 · External reference

Galectin-3 N-terminal tail prolines modulate cell activity and glycan-mediated oligomerization/phase separation

10.1073/pnas.2021074118 · 2021 · External reference

Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin

10.1016/s0021-9258(19)49693-2 · 1992 · External reference

Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors

10.1038/srep29457 · 2016 · External reference

Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation

10.1016/j.celrep.2015.02.012 · 2015 · External reference

AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings

10.1021/acs.jcim.1c00203 · 2021 · External reference

Targeting the CRD F-face of human galectin-3 and allosterically modulating glycan binding by angiostatic PTX008 and a structurally optimized derivative

10.1002/cmdc.202000742 · 2021 · External reference

Inhibition of soluble tumor necrosis factor is therapeutic in Huntington’s disease

10.1093/hmg/ddu151 · 2014 · External reference

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

10.1016/s0092-8674(00)81369-0 · 1996 · External reference

Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease

10.1016/j.nbd.2023.106376 · 2024 · External reference

Mutant Huntingtin is cleared from the brain via active mechanisms in Huntington disease

10.1523/jneurosci.1865-20.2020 · 2021 · External reference

Striatal projection neurons require Huntingtin for synaptic connectivity and survival

10.1016/j.celrep.2019.12.069 · 2020 · External reference

Inhibition of amyloid β aggregation and cytotoxicity by berbamine hydrochloride

10.1002/chem.202301865 · 2023 · External reference

Distinct molecular patterns in R6/2 HD mouse brain: Insights from spatiotemporal transcriptomics

10.1016/j.neuron.2025.05.014 · 2025 · External reference

Cell type-specific transcriptomics reveals that mutant huntingtin leads to mitochondrial RNA release and neuronal innate immune activation

10.1016/j.neuron.2020.06.021 · 2020 · External reference

Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation

10.1038/s41467-022-35388-x · 2022 · External reference

Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington’s disease

10.1016/j.nbd.2011.02.008 · 2011 · External reference

Galectin-3 aggravates microglial activation and tau transmission in tauopathy

10.1172/jci165523 · 2024 · External reference

Differential cellular expression of galectin-1 and galectin-3 after intracerebral hemorrhage

10.3389/fncel.2019.00157 · 2019 · External reference

Galectin-1 as a marker for microglia activation in the aging brain

10.1016/j.brainres.2023.148517 · 2023 · External reference

D1R- and D2R-medium-sized spiny neurons diversity: Insights into striatal vulnerability to Huntington’s disease mutation

10.3389/fncel.2021.628010 · 2021 · External reference

Balance between dopamine and adenosine signals regulates the PKA/Rap1 pathway in striatal medium spiny neurons

10.1016/j.neuint.2018.10.008 · 2019 · External reference

Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease

10.1172/jci57552 · 2011 · External reference

A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington’s disease

10.1093/hmg/ddt036 · 2013 · External reference

Artificial miRNA slows Huntington’s

10.1038/s41587-025-02910-7 · 2025 · External reference

Galectin-3 promotes Aβ oligomerization and Aβ toxicity in a mouse model of Alzheimer’s disease

10.1038/s41418-019-0348-z · 2020 · External reference

Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease

10.1007/s00401-022-02469-6 · 2022 · External reference

The role of Galectin-3 in α-synuclein-induced microglial activation

2014 · External reference

Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay

10.1080/15548627.2015.1063871 · 2015 · External reference

The cathepsin B inhibitor z-FA.fmk inhibits cytokine production in macrophages stimulated by lipopolysaccharide

10.1074/jbc.m102239200 · 2001 · External reference

A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response

10.1371/journal.pone.0098891 · 2014 · External reference

A core of kinase-regulated interactomes defines the neoplastic MDSC lineage

10.18632/oncotarget.4746 · 2015 · External reference

The potential of Valeriana as a traditional Chinese medicine: Traditional clinical applications, bioactivities, and phytochemistry

10.3389/fphar.2022.973138 · 2022 · External reference

Galectin-3 coordinates a cellular system for lysosomal repair and removal

10.1016/j.devcel.2019.10.025 · 2020 · External reference

Glycan dependence of Galectin-3 self-association properties

10.1371/journal.pone.0111836 · 2014 · External reference

Full-length galectin-3 is required for high affinity microbial interactions and antimicrobial activity

10.3389/fmicb.2021.731026 · 2021 · External reference

The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens

10.1155/2017/9247574 · 2017 · External reference

Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response

10.1084/jem.20090121 · 2010 · External reference

Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells

10.1074/jbc.m111.226423 · 2011 · External reference

Ligand induced galectin-3 protein self-association

10.1074/jbc.c112.358002 · 2012 · External reference

Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein

10.1016/j.apsb.2022.05.023 · 2022 · External reference

Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion

10.1371/journal.pntd.0010363 · 2022 · External reference

Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways

2018 · External reference

Prominent effects of berbamine hydrochloride on Alzheimer’s disease model mice

10.3389/fphar.2022.939039 · 2022 · External reference

Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value

10.1038/nn.3188 · 2012 · External reference

Basolateral to central amygdala neural circuits for appetitive behaviors

10.1016/j.neuron.2017.02.034 · 2017 · External reference

Alzheimer’s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits

10.2353/ajpath.2006.060002 · 2006 · External reference

Huntington’s disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels

10.18632/aging.101005 · 2016 · External reference